- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04698811
Virtual Eneagram: Quality of Life, Stress and Anxiety.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minas Gerais
-
Pouso Alegre, Minas Gerais, Brazil, 37554-210
- Univás
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Individuals of both sexes, Brazilians, adults, over 18 years old.
- Individuals who accept to sign the Informed Consent Form;
- Individuals with a desire to achieve self-awareness with the availability of time and access to the internet to hold meetings;
Exclusion Criteria:
- Individuals who drop out of work at any time;
- Individuals who have missed the modules and do not make a subsequent replacement;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: VIRTUAL ENEAGRAM: QUALITY OF LIFE, STRESS AND ANXIETY.
Training and testing battery.
|
Presentation of the Virtual Enneagram and its content and realization of the first battery of tests (World Health Organization Quality of Life - (WHOQOL-BREF). Stress Perception Scale 10 (EPS-10) The Trait-State Anxiety Inventory: IDATE E and T.) . Guidance and training on personality and the Enneagram, its classification system, personality subtypes and dynamics of stress and growth allowing self-recognition. Second test battery ((World Health Organization Quality of Life - (WHOQOL-BREF). Stress Perception Scale 10 (EPS-10) The Trait-State Anxiety Inventory: (IDATE E and T.) and Enneagram Questionnaire. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Analysis of the condition of anxiety, stress and quality of life of the participating individuals.
Time Frame: Up to 24 weeks
|
The data it will be tabulated in Microsoft Excel 2016 and submitted to statistical analysis, measures of central tendency were used for quantitative variables and absolute and relative frequency for categorical variables.
The Minitabversion 18.1 program and the Statistical Package for the Social Sciences, Inc. (SPSS) Chicago, USA, version 22.0, were used.
The level of significance used as a criterion for acceptance or rejection in the statistical tests was 5% (p <0.05).
|
Up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Analysis of the condition of anxiety, stress and quality of life of the participating after intervention with a virtual enneagram; .
Time Frame: through study completion, an average of 6 months
|
The data were tabulated in Microsoft Excel 2016 and submitted to statistical analysis, measures of central tendency were used for quantitative variables and absolute and relative frequency for categorical variables.
The Minitabversion 18.1 program and the Statistical Package for the Social Sciences, Inc. (SPSS) Chicago, USA, version 22.0, were used.
The level of significance used as a criterion for acceptance or rejection in the statistical tests was 5% (p <0.05).
|
through study completion, an average of 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perception of self-knowledge after study and training through the virtual enneagram
Time Frame: through study completion, an average of 6 months
|
The data were tabulated in Microsoft Excel 2016 and submitted to statistical analysis, measures of central tendency were used for quantitative variables and absolute and relative frequency for categorical variables.
The Minitabversion 18.1 program and the Statistical Package for the Social Sciences, Inc. (SPSS) Chicago, USA, version 22.0, were used.
The level of significance used as a criterion for acceptance or rejection in the statistical tests was 5% (p <0.05).
|
through study completion, an average of 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Fundação de Ensino Superior
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Personality
-
NHS Greater Glasgow and ClydeUnknownBorderline Personality Disorder (BPD) | Antisocial Personality Disorder (ASPD)United Kingdom
-
University Hospital, Basel, SwitzerlandLeading House for the Latin American Region (Seed Money Grant SMG 1730)WithdrawnBorderline Personality Disorder (BPD)
-
University of Colorado, DenverCompleted
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
-
Icahn School of Medicine at Mount SinaiCompletedBorderline Personality Disorders | Avoidant Personality DisordersUnited States
-
Norwegian University of Science and TechnologyCompletedPersonality Disorder, Borderline | Avoidant Personality DisorderNorway
-
University of RegensburgCompletedDepression | Personality Disorder, Borderline | Personality Disorder; UnstableGermany
-
Hospital Universitari Vall d'Hebron Research InstituteUnknownBorderline Personality Disorder.Spain
-
Universidad Nacional Autonoma de MexicoCompletedPsychopathic Personality TraitMexico
-
Silvia Elisa Hurtado SantiagoCompletedPersonality Disorder, BorderlineSpain
Clinical Trials on VIRTUAL ENEAGRAM
-
Institut National de la Santé Et de la Recherche...Not yet recruitingSchizophrenia | Bipolar Disorder
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongRecruiting
-
Universidad Rey Juan CarlosCompleted
-
University of PennsylvaniaNot yet recruitingEnd Stage Kidney Disease
-
HaEmek Medical Center, IsraelUnknown
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed